Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACS Diagnosis to Therapy Justin E Davies
Author(s): Justin E Davies Start date: Sep 01, 2015

Anticoagulation

Intervention
Acute Coronary Syndrome in Pre- and Post-partum Women – A Review
Author(s): Gianfranco Aprigliano , Altin Palloshi , Nuccia Morici , et al Added: 3 years ago
Cardiovascular diseases represent the leading cause of mortality in pregnancy.1,2 They are classified as direct (acute onset disease) or indirect (worsening of pre-existing cardiac disease). This overview is focused on acute coronary syndrome (ACS) in pregnancy and the post-partum period. ACS in this setting is a rare condition, but in the last two decades its incidence has grown.3 This… View more

Demographic
ESC 23: The STOPDAPT-3 Study
Author(s): Masahiro Natsuaki Added: 7 months ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111). In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at… View more

MI/ACS

Intervention
Author(s): Paul Guedeney , Birgit Vogel , Roxana Mehran Added: 3 years ago
Dual antiplatelet therapy (DAPT) including aspirin and a P2Y12 inhibitor is the current gold standard for the treatment and mid-term secondary prevention of acute coronary syndrome (ACS).1–4 However, despite the use of potent P2Y12 inhibitors such as ticagrelor or prasugrel, patients remain at high ischaemic risk after ACS. More specifically, in the prasugrel treatment arm of the TRial to Assess… View more

Anticoagulation

MI/ACS
Angiographic Characteristics in Older NSTEACS Patients
Author(s): Benjamin Beska , Hanna Ratcovich , Alan Bagnall , et al Added: 1 year ago

MI/ACS

Intervention
Author(s): Sasko Kedev Added: 3 years ago
An invasive strategy including percutaneous coronary intervention (PCI) improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and in high-risk patients with non-ST-segment elevation acute coronary syndrome (NSTEACS).1,2 The femoral approach (TFA) is the preferred and most widely used percutaneous access site in most cardiac catheterisation laboratories… View more

MI/ACS

Intervention
JIMPosters
Author(s): Inderjeet Singh Monga , Anil Kumar , R Girish , et al Added: 2 years ago

MI/ACS

Intervention
Thumbnail
Author(s): Francisco Hidalgo Added: 2 years ago
In this interview, Dr Francisco José Hidalgo Lesmes (University Hospital Reina Sofia, Cordoba, ES) outlines the findings of a multicenter observational registry evaluating the use of instantaneous wave-free ratio for the assessment of non-culprit lesions in patients with acute coronary syndrome. Questions: What was the rationale for this study? Can you describe the design, patient population and… View more

MI/ACS
Roxy Senior is Professor of Clinical Cardiology at the National Heart and Lung Institute, Imperial College London and Consultant Cardiologist and Director of Echocardiography at the Royal Brompton Hospital, London and Northwick Park Hospital, Harrow. He is a clinician with a major interest in echocardiography. He has been involved with echocardiography for the last 25 years and has published… View more